N@N

SBAC, TNS, MNKD, VVUS, UDR, ALNY Expected To Be Down After Next Earnings Releases

^{Published on 2011-07-29 06:12:37 - WOPRAI}
 

July 29, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Monday, August 1st 2011 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and June earnings reports. SBA COMMUNICATIONS CORP-CL A (NASDAQ:SBAC), TNS INC (NYSE:TNS), MANNKIND CORP (NASDAQ:MNKD), VIVUS INC (NASDAQ:VVUS), UDR INC (NYSE:UDR), ALNYLAM PHARMACEUTICALS INC (NASDAQ:ALNY) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Monday:

     Symbol     Company                             # of Reports            Quarter     Release Time
     SBAC       SBA COMMUNICATIONS CORP-CL A        6 Quarter               Q2          After
     TNS        TNS INC                             6 Quarter               Q2          After
     MNKD       MANNKIND CORP                       12 Quarter              Q2          Before
     VVUS       VIVUS INC                           12 Quarter              Q2          After
     UDR        UDR INC                             6 Quarter               Q2          Before
     ALNY       ALNYLAM PHARMACEUTICALS INC         12 Quarter              Q2          After

SBA COMMUNICATIONS CORP-CL A (NASDAQ:SBAC) - SBA Communications Corporation, through its subsidiaries, engages in the ownership and operation of wireless communications towers in the Continental United States, Puerto Rico, Canada, and the U.S. Virgin Islands. The company leases antenna space to wireless service providers on towers and other structures that it owns, manages, or leases from others. As of December 31, 2009, it owned 8,324 tower sites. SBA Communications also manages or leases approximately 5,100 actual or potential communications sites. In addition, the company assists wireless service providers in developing and maintaining wireless service networks, as well as offers various site development services, including network pre-design, site audits, identification of potential locations for towers and antennas, support in buying or leasing of the location, and assistance in obtaining zoning approvals and permits. Further, it provides tower and related site construction; antenna installation; and radio equipment installation, commissioning, and maintenance services. The company was founded in 1989 and is headquartered in Boca Raton, Florida.

TNS INC (NYSE:TNS) - TNS, Inc. provides networking, data communications, and value added services to retailers, banks, and payment processors worldwide. It also offers secure data and voice network services to the financial services industry. The company provides point-of-sale/point-of-service (POS) that provides data communications services to payment processors. It also markets its POS data communications services to entities responsible for the transmission of state lottery transactions, federal and state electronic benefits transfer, and healthcare transactions, as well as directly to various merchants and retailers. In addition, the company operates unaffiliated SS7 networks, which offer call signaling and database access services, including local number portability databases, line information databases, toll-free databases, calling name delivery databases, validation and fraud control services, and ID Plus for telephone name and address database; and VoIP peering and other telecommunication services, such as LEConnect data services and short message service offload services to wireline and wireless telecommunication service providers. In addition, TNS provides data and voice communications services to the financial services community in support of the Financial Information eXchange messaging protocol and other transaction-oriented trading applications. It provides services to customers in the United States and in 29 countries, including Canada and Mexico, as well as Europe, Latin America, and the Asia Pacific regions. TNS, Inc. was founded in 1990 and is based in Reston, Virginia.

MANNKIND CORP (NASDAQ:MNKD) - MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer. Its lead product candidate, AFREZZA, a rapid-acting insulin that has completed Phase III clinical trials for the treatment of diabetes in the United States, Europe, and Japan. The company is also preparing to initiate a Phase II study of MKC1106-MT in patients with advanced melanoma. Its products also include MKC253 (GLP-1), a Phase I clinical trials product for the treatment of type 2 diabetes; and MKC1106-PP, a Phase I clinical trials product for the treatment of diverse tumor types, metastatic diseases, and/or progressive, refractory disease. In addition, the company conducts preclinical studies of drug candidates, MKC204, which may have the potential to treat certain malignancies and inflammatory diseases; MKC180, an obesity compound; and MKC1106-NS, a cancer immunotherapy product. MannKind Corporation was founded in 1991 and is based in Valencia, California.

VIVUS INC (NASDAQ:VVUS) - VIVUS, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products for underserved markets in the United States. It offers MUSE, a minimally invasive therapy for erectile dysfunction. The companys investigational product pipeline includes Qnexa that has completed Phase 3 clinical trials for obesity, and Phase 2 clinical trials for diabetes and obstructive sleep apnea; Avanafil, which is in phase 3 clinical trials to treat erectile dysfunction; and Luramist, which has completed phase 2 clinical trials for the treatment of hypoactive sexual desire disorder in women. It has a development, licensing, and supply agreement with Tanabe Seiyaku Co., Ltd. for the development and commercialization of Avanafil; and licensing agreements with Acrux and its subsidiary to develop and commercialize Luramist and Evamist in the United States. The company was founded in 1991 and is headquartered in Mountain View, California.

UDR INC (NYSE:UDR) - UDR, Inc. formerly United Dominion Realty Trust, Inc., operates as a self-administered equity real estate investment trust (REIT). It owns, acquires, renovates, develops, and manages middle-market apartment communities. The company targets young professionals, blue-collar families, single parent households, older singles, immigrants, and non related parties. As of June 30, 2005, the companys portfolio included 263 communities with 77,289 apartment homes nationwide. As a REIT, the company would not be subject to federal income taxes to the extent it distributes 90% of its REIT taxable income to its stockholders. UDR, Inc. was founded in 1949 and is headquartered in Highlands Ranch, Colorado.

ALNYLAM PHARMACEUTICALS INC (NASDAQ:ALNY) - Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics based on RNA interference (RNAi). Its lead RNAi therapeutic program includes ALN-RSV01, which is in Phase II clinical trial for the treatment of human respiratory syncytial virus (RSV) infection. The companys product pipeline also comprises ALN-VSP, a Phase I clinical trial product to treat liver cancers. Its products under development stage include ALN-RSV02 for the treatment of RSV infection; ALN TTR01 and ALN TTR02 to treat TTR-Mediated Amyloidosis; ALN-PCS for the treatment of PCSK9/Hypercholesterolemia; and ALN-HTT to treat Huntingtons disease. It has license and collaboration agreements with Roche to develop and commercialize therapeutic products that function through RNAi; Takeda for the development and commercialization of RNAi therapeutics; and with Medtronic Inc. and CHDI Foundation, Inc. to advance ALN-HTT, a novel drug-device combination for the treatment of Huntington's disease. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641